Search results
Results from the WOW.Com Content Network
In March 2019, the FDA approved an additional generic version of valsartan to address the issue. [64] According to the agency, the shortage of valsartan was resolved in April 2020, [65] but the availability of the generic form remained unstable into July 2020. Pharmacies in the European Union were notified that the supply of the drug ...
Valsartan/hydrochlorothiazide, sold under the brand name Diovan HCT among others, is a medication used to treat high blood pressure when valsartan is not sufficient. [6] It is a combination of valsartan, an angiotensin receptor blocker with hydrochlorothiazide , a diuretic . [ 7 ]
Sacubitril/valsartan, sold under the brand name Entresto among others, is a fixed-dose combination medication for use in heart failure.It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan.
Hydrochlorothiazide, sold under the brand name Hydrodiuril among others, is a diuretic medication used to treat hypertension and swelling due to fluid build-up. [4] Other uses include treating diabetes insipidus and renal tubular acidosis and to decrease the risk of kidney stones in those with a high calcium level in the urine. [4]
Candesartan is an angiotensin receptor blocker used mainly for the treatment of high blood pressure and congestive heart failure.Candesartan has a very low maintenance dose.
Cariprazine is used to treat patients with schizophrenia and manic, depressive, or mixed episodes associated with bipolar I disorder.In the United States it is approved for schizophrenia in adults, acute treatment of manic or mixed episodes associated with bipolar I disorder in adults and treatment of depressive episodes associated with bipolar I disorder (bipolar depression).
This pharmacology -related article is a stub. You can help Wikipedia by expanding it.
Rivaroxaban inhibits both free and bound Factor Xa in the prothrombinase complex. [33] It is a selective direct factor Xa inhibitor with an onset of action of 2.5 to 4 hours. [ 34 ] Inhibition of Factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade , inhibiting both thrombin formation and development of thrombi.